Table 2 Antibiotic use in the baseline and postintervention periods
Measures | Baseline n = 71 | Postintervention n = 66 | Incidence rate difference 95% CI | Relative difference % | p value | |
|---|---|---|---|---|---|---|
DOTs total | 887.3 | 333 | ||||
DOT total/1000 PDs | 63 | 25.8 | 37.1 (32.1–42) | 59.1 | < 0.001 | |
DOTs ampicillin DOTs ampicillin/1000 PDs | 432.3 30.68 | 157.1 12.18 | 18.5 (15–22) | 60.3 | < 0.001 | |
DOTs gentamicin DOTs gentamicin/1000 PDs | 439 31.1 | 168 13 | 18.1 (14.5–21.6) | 58.1 | < 0.001 | |
DOTs cephotaxime DOTs cephotaxime/1000 PDs | 16 1.1 | 7.8 0.6 | 0.5 (0.19–1.2) | 45.4 | 0.08 | |
AUR (%) | 3.2 | 1.3 | 1.9 (1.6–2.3) | 59.3 | < 0.001 | |
ASI/LOT, median (IQR) | 7.0 (6.3–7.0) | 7.0 (6.7–7.0) | - | 0.87 | ||
LOT, days, median (IQR) | 7 (6–7) | 2.5 (2.0–3.0) | - | < 0.001 |